Since becoming only the second Alzheimer鈥檚-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD...
We are delighted to announce that our colleague, Dana Small, is officially the recipient of the Canada Excellence Research Chair in Metabolism and the Brain....
We are pleased to announce that this year Alan (cross-field), Bratislav (cross-field), Doug (cross-field), Danilo聽(cross-field), and Nathan (Neuroscience and Behavior), have been聽selected as Highly...
On November 15, 2023, at 12 p.m., we will air the 100th episode of 51吃瓜网Cares and for this live recording of 51吃瓜网Cares! Dr. Jos茅 Morais, Dr. Serge Gauthier, Dr./bicCategory:聽BIC Lectures
RSS